Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Drugs. This report contains market size and forecasts of Gastrointestinal Drugs in global, including the following market information:
Global Gastrointestinal Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gastrointestinal Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Gastrointestinal Drugs companies in 2022 (%)
The global Gastrointestinal Drugs market was valued at US$ 35710 million in 2022 and is projected to reach US$ 44110 million by 2029, at a CAGR of 3.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.
Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.
In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.
We surveyed the Gastrointestinal Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastrointestinal Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastrointestinal Drugs Market Segment Percentages, by Type, 2022 (%)
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Global Gastrointestinal Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastrointestinal Drugs Market Segment Percentages, by Application, 2022 (%)
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other
Global Gastrointestinal Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastrointestinal Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastrointestinal Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gastrointestinal Drugs revenues share in global market, 2022 (%)
Key companies Gastrointestinal Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gastrointestinal Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria (Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastrointestinal Drugs, market overview.
Chapter 2: Global Gastrointestinal Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastrointestinal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastrointestinal Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Drugs Overall Market Size
2.1 Global Gastrointestinal Drugs Market Size: 2022 VS 2029
2.2 Global Gastrointestinal Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gastrointestinal Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Gastrointestinal Drugs Players in Global Market
3.2 Top Global Gastrointestinal Drugs Companies Ranked by Revenue
3.3 Global Gastrointestinal Drugs Revenue by Companies
3.4 Global Gastrointestinal Drugs Sales by Companies
3.5 Global Gastrointestinal Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gastrointestinal Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gastrointestinal Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastrointestinal Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gastrointestinal Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastrointestinal Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Drugs Market Size Markets, 2022 & 2029
4.1.2 Prescription Gastrointestinal Drug
4.1.3 OTC Gastrointestinal Drug
4.2 By Type - Global Gastrointestinal Drugs Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Drugs Revenue, 2018-2023
4.2.2 By Type - Global Gastrointestinal Drugs Revenue, 2024-2029
4.2.3 By Type - Global Gastrointestinal Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Gastrointestinal Drugs Sales & Forecasts
4.3.1 By Type - Global Gastrointestinal Drugs Sales, 2018-2023
4.3.2 By Type - Global Gastrointestinal Drugs Sales, 2024-2029
4.3.3 By Type - Global Gastrointestinal Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Gastrointestinal Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Drugs Market Size, 2022 & 2029
5.1.2 Chronic Gastritis
5.1.3 Functional Dyspepsia
5.1.4 Peptic Ulcer
5.1.5 Acute Gastroenteritis
5.1.6 Other
5.2 By Application - Global Gastrointestinal Drugs Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Drugs Revenue, 2018-2023
5.2.2 By Application - Global Gastrointestinal Drugs Revenue, 2024-2029
5.2.3 By Application - Global Gastrointestinal Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Gastrointestinal Drugs Sales & Forecasts
5.3.1 By Application - Global Gastrointestinal Drugs Sales, 2018-2023
5.3.2 By Application - Global Gastrointestinal Drugs Sales, 2024-2029
5.3.3 By Application - Global Gastrointestinal Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Gastrointestinal Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Gastrointestinal Drugs Market Size, 2022 & 2029
6.2 By Region - Global Gastrointestinal Drugs Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Drugs Revenue, 2018-2023
6.2.2 By Region - Global Gastrointestinal Drugs Revenue, 2024-2029
6.2.3 By Region - Global Gastrointestinal Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Gastrointestinal Drugs Sales & Forecasts
6.3.1 By Region - Global Gastrointestinal Drugs Sales, 2018-2023
6.3.2 By Region - Global Gastrointestinal Drugs Sales, 2024-2029
6.3.3 By Region - Global Gastrointestinal Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Gastrointestinal Drugs Revenue, 2018-2029
6.4.2 By Country - North America Gastrointestinal Drugs Sales, 2018-2029
6.4.3 US Gastrointestinal Drugs Market Size, 2018-2029
6.4.4 Canada Gastrointestinal Drugs Market Size, 2018-2029
6.4.5 Mexico Gastrointestinal Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Gastrointestinal Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Gastrointestinal Drugs Sales, 2018-2029
6.5.3 Germany Gastrointestinal Drugs Market Size, 2018-2029
6.5.4 France Gastrointestinal Drugs Market Size, 2018-2029
6.5.5 U.K. Gastrointestinal Drugs Market Size, 2018-2029
6.5.6 Italy Gastrointestinal Drugs Market Size, 2018-2029
6.5.7 Russia Gastrointestinal Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Gastrointestinal Drugs Market Size, 2018-2029
6.5.9 Benelux Gastrointestinal Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Gastrointestinal Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Gastrointestinal Drugs Sales, 2018-2029
6.6.3 China Gastrointestinal Drugs Market Size, 2018-2029
6.6.4 Japan Gastrointestinal Drugs Market Size, 2018-2029
6.6.5 South Korea Gastrointestinal Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Gastrointestinal Drugs Market Size, 2018-2029
6.6.7 India Gastrointestinal Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Gastrointestinal Drugs Revenue, 2018-2029
6.7.2 By Country - South America Gastrointestinal Drugs Sales, 2018-2029
6.7.3 Brazil Gastrointestinal Drugs Market Size, 2018-2029
6.7.4 Argentina Gastrointestinal Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastrointestinal Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Gastrointestinal Drugs Sales, 2018-2029
6.8.3 Turkey Gastrointestinal Drugs Market Size, 2018-2029
6.8.4 Israel Gastrointestinal Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Gastrointestinal Drugs Market Size, 2018-2029
6.8.6 UAE Gastrointestinal Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Gastrointestinal Drugs Major Product Offerings
7.1.4 AstraZeneca Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Gastrointestinal Drugs Major Product Offerings
7.2.4 Sanofi Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Gastrointestinal Drugs Major Product Offerings
7.3.4 Bayer Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Gastrointestinal Drugs Major Product Offerings
7.4.4 Pfizer Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Gastrointestinal Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Teva
7.6.1 Teva Company Summary
7.6.2 Teva Business Overview
7.6.3 Teva Gastrointestinal Drugs Major Product Offerings
7.6.4 Teva Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Teva Key News & Latest Developments
7.7 Zeria (Tillotts)
7.7.1 Zeria (Tillotts) Company Summary
7.7.2 Zeria (Tillotts) Business Overview
7.7.3 Zeria (Tillotts) Gastrointestinal Drugs Major Product Offerings
7.7.4 Zeria (Tillotts) Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Zeria (Tillotts) Key News & Latest Developments
7.8 Perrigo
7.8.1 Perrigo Company Summary
7.8.2 Perrigo Business Overview
7.8.3 Perrigo Gastrointestinal Drugs Major Product Offerings
7.8.4 Perrigo Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Perrigo Key News & Latest Developments
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Gastrointestinal Drugs Major Product Offerings
7.9.4 Boehringer Ingelheim Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Boehringer Ingelheim Key News & Latest Developments
7.10 Purdue Pharma
7.10.1 Purdue Pharma Company Summary
7.10.2 Purdue Pharma Business Overview
7.10.3 Purdue Pharma Gastrointestinal Drugs Major Product Offerings
7.10.4 Purdue Pharma Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Purdue Pharma Key News & Latest Developments
7.11 C.B. Fleet
7.11.1 C.B. Fleet Company Summary
7.11.2 C.B. Fleet Gastrointestinal Drugs Business Overview
7.11.3 C.B. Fleet Gastrointestinal Drugs Major Product Offerings
7.11.4 C.B. Fleet Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.11.5 C.B. Fleet Key News & Latest Developments
7.12 Abbott
7.12.1 Abbott Company Summary
7.12.2 Abbott Gastrointestinal Drugs Business Overview
7.12.3 Abbott Gastrointestinal Drugs Major Product Offerings
7.12.4 Abbott Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Abbott Key News & Latest Developments
7.13 Jiangzhong
7.13.1 Jiangzhong Company Summary
7.13.2 Jiangzhong Gastrointestinal Drugs Business Overview
7.13.3 Jiangzhong Gastrointestinal Drugs Major Product Offerings
7.13.4 Jiangzhong Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Jiangzhong Key News & Latest Developments
7.14 Xian-Janssen
7.14.1 Xian-Janssen Company Summary
7.14.2 Xian-Janssen Business Overview
7.14.3 Xian-Janssen Gastrointestinal Drugs Major Product Offerings
7.14.4 Xian-Janssen Gastrointestinal Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Xian-Janssen Key News & Latest Developments
8 Global Gastrointestinal Drugs Production Capacity, Analysis
8.1 Global Gastrointestinal Drugs Production Capacity, 2018-2029
8.2 Gastrointestinal Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastrointestinal Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastrointestinal Drugs Supply Chain Analysis
10.1 Gastrointestinal Drugs Industry Value Chain
10.2 Gastrointestinal Drugs Upstream Market
10.3 Gastrointestinal Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastrointestinal Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Gastrointestinal Drugs in Global Market
Table 2. Top Gastrointestinal Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gastrointestinal Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gastrointestinal Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Gastrointestinal Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Gastrointestinal Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gastrointestinal Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Gastrointestinal Drugs Product Type
Table 9. List of Global Tier 1 Gastrointestinal Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gastrointestinal Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Gastrointestinal Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gastrointestinal Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Gastrointestinal Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Gastrointestinal Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Gastrointestinal Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Gastrointestinal Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gastrointestinal Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Gastrointestinal Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Gastrointestinal Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Gastrointestinal Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Gastrointestinal Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gastrointestinal Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Gastrointestinal Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Gastrointestinal Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gastrointestinal Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Gastrointestinal Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Gastrointestinal Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gastrointestinal Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Gastrointestinal Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Gastrointestinal Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gastrointestinal Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Gastrointestinal Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Gastrointestinal Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gastrointestinal Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Gastrointestinal Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Gastrointestinal Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gastrointestinal Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Gastrointestinal Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Gastrointestinal Drugs Sales, (K Units), 2024-2029
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Gastrointestinal Drugs Product Offerings
Table 48. AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Gastrointestinal Drugs Product Offerings
Table 52. Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Gastrointestinal Drugs Product Offerings
Table 56. Bayer Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Gastrointestinal Drugs Product Offerings
Table 60. Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Gastrointestinal Drugs Product Offerings
Table 64. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Teva Company Summary
Table 67. Teva Gastrointestinal Drugs Product Offerings
Table 68. Teva Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Teva Key News & Latest Developments
Table 70. Zeria (Tillotts) Company Summary
Table 71. Zeria (Tillotts) Gastrointestinal Drugs Product Offerings
Table 72. Zeria (Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Zeria (Tillotts) Key News & Latest Developments
Table 74. Perrigo Company Summary
Table 75. Perrigo Gastrointestinal Drugs Product Offerings
Table 76. Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Perrigo Key News & Latest Developments
Table 78. Boehringer Ingelheim Company Summary
Table 79. Boehringer Ingelheim Gastrointestinal Drugs Product Offerings
Table 80. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Boehringer Ingelheim Key News & Latest Developments
Table 82. Purdue Pharma Company Summary
Table 83. Purdue Pharma Gastrointestinal Drugs Product Offerings
Table 84. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Purdue Pharma Key News & Latest Developments
Table 86. C.B. Fleet Company Summary
Table 87. C.B. Fleet Gastrointestinal Drugs Product Offerings
Table 88. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. C.B. Fleet Key News & Latest Developments
Table 90. Abbott Company Summary
Table 91. Abbott Gastrointestinal Drugs Product Offerings
Table 92. Abbott Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Abbott Key News & Latest Developments
Table 94. Jiangzhong Company Summary
Table 95. Jiangzhong Gastrointestinal Drugs Product Offerings
Table 96. Jiangzhong Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Jiangzhong Key News & Latest Developments
Table 98. Xian-Janssen Company Summary
Table 99. Xian-Janssen Gastrointestinal Drugs Product Offerings
Table 100. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Xian-Janssen Key News & Latest Developments
Table 102. Gastrointestinal Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Gastrointestinal Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Gastrointestinal Drugs Production by Region, 2018-2023 (K Units)
Table 105. Global Gastrointestinal Drugs Production by Region, 2024-2029 (K Units)
Table 106. Gastrointestinal Drugs Market Opportunities & Trends in Global Market
Table 107. Gastrointestinal Drugs Market Drivers in Global Market
Table 108. Gastrointestinal Drugs Market Restraints in Global Market
Table 109. Gastrointestinal Drugs Raw Materials
Table 110. Gastrointestinal Drugs Raw Materials Suppliers in Global Market
Table 111. Typical Gastrointestinal Drugs Downstream
Table 112. Gastrointestinal Drugs Downstream Clients in Global Market
Table 113. Gastrointestinal Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastrointestinal Drugs Segment by Type in 2022
Figure 2. Gastrointestinal Drugs Segment by Application in 2022
Figure 3. Global Gastrointestinal Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gastrointestinal Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Gastrointestinal Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gastrointestinal Drugs Revenue in 2022
Figure 9. By Type - Global Gastrointestinal Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Gastrointestinal Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Gastrointestinal Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Gastrointestinal Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Gastrointestinal Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Gastrointestinal Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Gastrointestinal Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Gastrointestinal Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Gastrointestinal Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Gastrointestinal Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Gastrointestinal Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Gastrointestinal Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Gastrointestinal Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Gastrointestinal Drugs Sales Market Share, 2018-2029
Figure 23. US Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Gastrointestinal Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Gastrointestinal Drugs Sales Market Share, 2018-2029
Figure 28. Germany Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Gastrointestinal Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Gastrointestinal Drugs Sales Market Share, 2018-2029
Figure 37. China Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Gastrointestinal Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Gastrointestinal Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Gastrointestinal Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Gastrointestinal Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Gastrointestinal Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Gastrointestinal Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Gastrointestinal Drugs by Region, 2022 VS 2029
Figure 54. Gastrointestinal Drugs Industry Value Chain
Figure 55. Marketing Channels
